ASX - By Stock
|
PEB |
Re:
Ann: Clinical Utility of Cxbladder to Headline at AUA 2024
|
|
uktion
|
7 |
1.0K |
1 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
7
|
1.0K
|
1
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Clinical Utility of Cxbladder to Headline at AUA 2024
|
|
uktion
|
7 |
1.0K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
7
|
1.0K
|
1
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Clinical Utility of Cxbladder to Headline at AUA 2024
|
|
uktion
|
7 |
1.0K |
0 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
7
|
1.0K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
uktion
|
3 |
1.3K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
3
|
1.3K
|
0
|
|
ASX - By Stock
|
PEB |
Cxbladder March 2024 update
|
|
uktion
|
0 |
212 |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
0
|
212
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Half Year Results and Trading Update
|
|
uktion
|
3 |
2.1K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
3
|
2.1K
|
1
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
uktion
|
6 |
3.9K |
2 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
6
|
3.9K
|
2
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
uktion
|
6 |
3.9K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
6
|
3.9K
|
1
|
|
ASX - By Stock
|
HYD |
Re:
Action?
|
|
uktion
|
8 |
4.1K |
0 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
8
|
4.1K
|
0
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Quarterly Update - Test Volumes Fall Following Restructure
|
|
uktion
|
1 |
643 |
0 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
1
|
643
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Action?
|
|
uktion
|
8 |
4.1K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
8
|
4.1K
|
1
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Financial Results for the Half Year to 30 September 2023
|
|
uktion
|
8 |
3.0K |
1 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
8
|
3.0K
|
1
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Capital Raising Presentation
|
|
uktion
|
28 |
8.8K |
0 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
28
|
8.8K
|
0
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Financial Results for the Half Year to 30 September 2023
|
|
uktion
|
8 |
3.0K |
0 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
8
|
3.0K
|
0
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Financial Results for the Half Year to 30 September 2023
|
|
uktion
|
8 |
3.0K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
8
|
3.0K
|
0
|
|
ASX - By Stock
|
CGS |
Re:
Ann: Share Buyback Update
|
|
uktion
|
6 |
3.5K |
1 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
6
|
3.5K
|
1
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Kaiser Permanente EMR Integration goes live
|
|
uktion
|
1 |
615 |
1 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
1
|
615
|
1
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Trading Halt
|
|
uktion
|
74 |
26K |
0 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
74
|
26K
|
0
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Quarterly Update - Q2 24 Cxbladder Test Volumes Resilient
|
|
uktion
|
2 |
634 |
0 |
22/10/23 |
22/10/23 |
ASX - By Stock
|
2
|
634
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: $4.5 million Entitlement Offer
|
|
uktion
|
37 |
17K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
37
|
17K
|
0
|
|
ASX - By Stock
|
PEB |
Re:
Ann: Quarterly Update - Q2 24 Cxbladder Test Volumes Resilient
|
|
uktion
|
2 |
634 |
0 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
2
|
634
|
0
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Change of Director's Interest Notice - K Quirke
|
|
uktion
|
8 |
3.7K |
0 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
8
|
3.7K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Update on Avertix Medical Business Combination
|
|
uktion
|
3 |
1.5K |
0 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
3
|
1.5K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Notice under Section 708A - Cleansing Notice
|
|
uktion
|
25 |
12K |
1 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
25
|
12K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Non-Cash Impairment of Intangible Assets
|
|
uktion
|
7 |
2.4K |
0 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
7
|
2.4K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Non-Cash Impairment of Intangible Assets
|
|
uktion
|
7 |
2.4K |
0 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
7
|
2.4K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Investor Presentation
|
|
uktion
|
2 |
1.4K |
4 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
2
|
1.4K
|
4
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
uktion
|
5 |
3.5K |
0 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
5
|
3.5K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Proposed issue of securities - LBT
|
|
uktion
|
20 |
8.6K |
1 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
20
|
8.6K
|
1
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Hydrix signs agreement to sell EIQ's EchoSolv platform
|
|
uktion
|
28 |
16K |
1 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
28
|
16K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
uktion
|
25 |
6.9K |
1 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
25
|
6.9K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
uktion
|
25 |
6.9K |
7 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
25
|
6.9K
|
7
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Hydrix signs agreement to sell EIQ's EchoSolv platform
|
|
uktion
|
28 |
16K |
0 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
28
|
16K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Hydrix signs agreement to sell EIQ's EchoSolv platform
|
|
uktion
|
28 |
16K |
0 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
28
|
16K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Hydrix signs agreement to sell EIQ's EchoSolv platform
|
|
uktion
|
28 |
16K |
0 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
28
|
16K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Hydrix signs agreement to sell EIQ's EchoSolv platform
|
|
uktion
|
28 |
16K |
1 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
28
|
16K
|
1
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Hydrix signs agreement to sell EIQ's EchoSolv platform
|
|
uktion
|
28 |
16K |
0 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
28
|
16K
|
0
|
|
ASX - By Stock
|
CGS |
Re:
Ann: Change in substantial shareholding from AEF
|
|
uktion
|
10 |
5.4K |
1 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
10
|
5.4K
|
1
|
|
ASX - By Stock
|
UCM |
Re:
Tax loss selling
|
|
uktion
|
12 |
1.8K |
0 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
12
|
1.8K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: TGA response to Guardian application
|
|
uktion
|
33 |
18K |
1 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
33
|
18K
|
1
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Trading halt
|
|
uktion
|
15 |
6.0K |
0 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
15
|
6.0K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Trading halt
|
|
uktion
|
15 |
6.0K |
1 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
15
|
6.0K
|
1
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Trading halt
|
|
uktion
|
15 |
6.0K |
2 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
15
|
6.0K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: AstraZeneca Partners LBT for APAS Pharma Development
|
|
uktion
|
12 |
7.2K |
1 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
12
|
7.2K
|
1
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Appendix 3Y x4
|
|
uktion
|
1 |
748 |
1 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
1
|
748
|
1
|
|
ASX - By Stock
|
UCM |
Re:
Ann: Uscom China Recognised as Innovative SMEs by Beijing DRC
|
|
uktion
|
38 |
9.0K |
0 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
38
|
9.0K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Results of Loyalty Options Offer
|
|
uktion
|
5 |
2.6K |
0 |
06/12/22 |
06/12/22 |
ASX - By Stock
|
5
|
2.6K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Quarterly update and Appendix 4C
|
|
uktion
|
13 |
6.0K |
1 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
13
|
6.0K
|
1
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Quarterly update and Appendix 4C
|
|
uktion
|
13 |
6.0K |
0 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
13
|
6.0K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Results of Meeting
|
|
uktion
|
33 |
15K |
0 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
33
|
15K
|
0
|
|